Do pregnancy-related changes in the microbiome stimulate innate immunity?

Trends in Molecular Medicine

Volumn 19, Issue 8, 2013, Pages 454-459

  Konstantinov, Sergey R ^a   van der Woude, C Janneke ^a   Peppelenbosch, Maikel P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Anti TNF ; Autoimmunity; IBD; Microbiome; Pregnancy

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADAPTATION; ADAPTIVE IMMUNITY; CESAREAN SECTION; COLITIS; CROHN DISEASE; CYTOKINE RELEASE; HUMAN; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MICROBIOME; MICROFLORA; MOTHER; NONHUMAN; PREGNANCY; REGULATORY T LYMPHOCYTE; REVIEW; ULCERATIVE COLITIS; WEIGHT GAIN;

EID: 84881030000     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2013.06.002     Document Type: Review

References (38)

1. Castiglione F., et al. Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease. Ital. J. Gastroenterol. 1996, 28:199-204.
2. Riis L., et al. Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease. Am. J. Gastroenterol. 2006, 101:1539-1545.
3. Zelinkova Z., et al. Effects of discontinuing anti-tumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposure. Clin. Gastroenterol. Hepatol. 2013, 11:318-321.
4. Østensen M., et al. Interaction of pregnancy and autoimmune rheumatic disease. Autoimmun. Rev. 2012, 11:A437-A446.
5. Munoz-Suano A., et al. Gimme shelter: the immune system during pregnancy. Immunol. Rev. 2011, 241:20-38.
6. Hooper L.V., et al. Interactions between the microbiota and the immune system. Science 2012, 336:1268-1273.
7. de Vos W.M., de Vos E.A.J. Role of the intestinal microbiome in health and disease: from correlation to causation. Nutr. Rev. 2012, 70:S45-S56.
8. Koren O., et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 2012, 150:470-480.
9. Lepage P., et al. Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology 2011, 141:227-236.
10. Aagaard K., et al. A metagenomic approach to characterization of the vaginal microbiome signature in pregnancy. PLoS ONE 2012, 7:e36466.
11. Rautava S., et al. Microbial contact during pregnancy, intestinal colonization and human disease. Nat. Rev. Gastroenterol. Hepatol. 2012, 9:565-576.
12. Satokari R., et al. Bifidobacterium and Lactobacillus DNA in the human placenta. Lett. Appl. Microbiol. 2009, 48:8-12.
13. Turnbaugh P.J., et al. A core gut microbiome in obese and lean twins. Nature 2009, 457:480-484.
14. Vrieze A., et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012, 143:913-916.
15. Okogbule-Wonodi A.C., et al. Necrotizing enterocolitis is associated with Ureaplasma colonization in preterm infants. Pediatr. Res. 2011, 69:442-447.
16. Dominguez-Bello M.G., et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:11971-11975.
17. Favier C.F., et al. Molecular monitoring of succession of bacterial communities in human neonates. Appl. Environ. Microbiol. 2002, 68:219-226.
18. Penders J., et al. Factors influencing the composition of the intestinal microbiota in early Infancy. Pediatrics 2006, 118:511-521.
19. Koenig J.E., et al. Succession of microbial consortia in the developing infant gut microbiome. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:4578-4585.
20. Ostensen M., Villiger P.M. Immunology of pregnancy - pregnancy as a remission inducing agent in rheumatoid arthritis. Transpl. Immunol. 2002, 9:155-160.
21. Sturm A., et al. Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn's disease and ulcerative colitis. Gut 2004, 53:1624-1631.
22. MacDonald T.T., Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005, 307:1920-1925.
23. Van den Brande J.M.H., et al. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. Gastroenterology 2003, 124:1774-1785.
24. Papadakis K.A., Targan S.R. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu. Rev. Med. 2000, 51:289-298.
25. Van den Brande J.M.H., et al. Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn's disease. Gut 2007, 56:509-517.
26. Waetzig G.H., et al. Differential p38 mitogen-activated protein kinase target phosphorylation in responders and nonresponders to infliximab. Gastroenterology 2003, 125:633-634.
27. Di Sabatino A., et al. Functional modulation of Crohn's disease myofibroblasts by anti-tumor necrosis factor antibodies. Gastroenterology 2007, 133:137-149.
28. Johnson G.L., Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298:1911-1912.
29. Rakoff-Nahoum S., et al. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229-241.
30. Rakoff-Nahoum S., Medzhitov R. Innate immune recognition of the indigenous microbial flora. Mucosal Immunol. 2011, 1:S10-S14.
31. Comalada M., Peppelenbosch M.P. Impaired innate immunity in Crohn's disease. Trends Mol. Med. 2006, 12:397-399.
32. Sewell G.W., et al. Defective tumor necrosis factor release from Crohn's disease macrophages in response to Toll-like receptor activation: relationship to phenotype and genome-wide association susceptibility loci. Inflamm. Bowel Dis. 2012, 18:2120-2127.
33. Smith A.M., et al. Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J. Exp. Med. 2009, 206:1883-1897.
34. Campos N., et al. Macrophages from IBD patients exhibit defective tumour necrosis factor-α secretion but otherwise normal or augmented pro-inflammatory responses to infection. Immunobiology 2011, 216:961-970.
35. Marks D.J.B., et al. Defective acute inflammation in Crohn's disease: a clinical investigation. Lancet 2006, 367:668-678.
36. Rettew J.A., et al. Estrogens augment cell surface TLR4 expression on murine macrophages and regulate sepsis susceptibility in vivo. Endocrinology 2009, 150:3877-3884.
37. Fukuyama A., et al. Anti-inflammatory effect of proteoglycan and progesterone on human uterine cervical fibroblasts. Life Sci. 2012, 90:484-488.
38. Dewint P., et al. Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI). Gut 2013, 10.1136/gutjnl-2013-304488.